coronary artery disease
Conditions
Interventions
experimental group:DCB-only
control group:The main branch was implanted with stent, and the branch was treated with drug balloon.
Sponsors
China-Japan Union Hospital of Jilin University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: The eligible patients were male and non-pregnant female patients with true coronary bifurcation disease (Medina type 1,1,1;1,0,1;0,1,1) Branch diameter 2.0-3.5mm, stenosis >= 70%, length = grade 3; branch residual stenosis < 50% after pretreatment.
Exclusion criteria
Exclusion criteria: 1. Unprotected left main artery disease and its branches; 2. In-stent restenosis; 3. Severe calcification or unsuitable balloon dilatation; 4. Life expectancy less than 1 year; 5. Severe heart failure (NYHA heart function grade, heart function >= III) or left ventricular ejection fraction < 35%; 6. Unable to tolerate dual antiplatelet therapy for 12 months; 7. Higher risk of bleeding (patients with high risk and above risk grades were excluded by CRUSADE score). 8. It is not possible to provide written informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| late lumen loss;Branch opening area; | — |
Secondary
| Measure | Time frame |
|---|---|
| MACE(major adverse cardiac enents) during follow-up; | — |
Countries
China
Contacts
Public ContactYuquan He
China-Japan Union Hospital of Jilin University
Outcome results
None listed